Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Using publicly available data to identify priority communities for a SARS-CoV-2 testing intervention in a southern U.S. state

View ORCID ProfileLynn T Matthews, Dustin M Long, Madeline C Pratt, Ya Yuan, Sonya L Heath, Emily B Levitan, Sydney Grooms, Thomas Creger, Aadia Rana, Michael J Mugavero, Suzanne E Judd the COVID COMET RADXUP Team
doi: https://doi.org/10.1101/2023.01.31.23285248
Lynn T Matthews
1Division of Infectious Disease, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lynn T Matthews
  • For correspondence: lynnmatthews{at}uabmc.edu
Dustin M Long
2Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Madeline C Pratt
1Division of Infectious Disease, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ya Yuan
2Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sonya L Heath
1Division of Infectious Disease, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily B Levitan
3Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sydney Grooms
4Center for AIDS Research, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Creger
4Center for AIDS Research, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aadia Rana
1Division of Infectious Disease, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J Mugavero
1Division of Infectious Disease, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
4Center for AIDS Research, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suzanne E Judd
5Center for the Study of Community Health, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The U.S. Southeast has a high burden of SARS-CoV-2 infections and COVID-19 disease. We used public data sources and community engagement to prioritize county selections for a precision population health intervention to promote a SARS-CoV-2 testing intervention in rural Alabama during October 2020 and March 2021.

Methods We modeled factors associated with county-level SARS-CoV-2 percent positivity using covariates thought to associate with SARS-CoV-2 acquisition risk, disease severity, and risk mitigation practices. Descriptive epidemiologic data were presented to scientific and community advisory boards to prioritize counties for a testing intervention.

Results In October 2020, SARS-CoV-2 percent positivity was not associated with any modeled factors. In March 2021, premature death rate (aRR 1.16, 95% CI 1.07, 1.25), percent Black residents (aRR 1.00, 95% CI 1.00, 1.01), preventable hospitalizations (aRR 1.03, 95% CI 1.00, 1.06), and proportion of smokers (aRR 0.231, 95% CI 0.10, 0.55) were associated with average SARS-CoV-2 percent positivity. We then ranked counties based on percent positivity, case fatality, case rates, and number of testing sites using individual variables and factor scores. Top ranking counties identified through factor analysis and univariate associations were provided to community partners who considered ongoing efforts and strength of community partnerships to promote testing to inform intervention.

Conclusions The dynamic nature of SARS-CoV-2 proved challenging for a modelling approach to inform a precision population health intervention at the county level. Epidemiological data allowed for engagement of community stakeholders implementing testing. As data sources and analytic capacities expand, engaging communities in data interpretation is vital to address diseases locally.

Competing Interest Statement

LT Matthews, Operational support from Gilead Sciences for unrelated projects. E. Levitan. Research funding from Amgen, Inc. unrelated to this work. Personal fees for a research project funded by Novartis, for work unrelated to this publication. MJ Mugavero, grant support to UAB from Merck Foundation for unrelated project. This is work supported by NIH: the funders had no role in the interpretation, analysis, or communication of the findings.

Funding Statement

NIH RADx-Up initiative, UAB Center for AIDS Research, COVID COMET AL, Project #P30AI027767-32S1 (PI Michael Saag) The funder provided support in the form of salaries for authors [LTM, DML, YY, SH, EBL, TC, MJM, and SEJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Data were downloaded periodically (approximately quarterly) from publicly available websites that collated and created visual representations of data reported by the Alabama Department of Public Health (ADPH). For the October 2020 county testing selections, data were downloaded from bamatracker.com, a website that collated and displayed data from ADPH through May 2021. In the March 2021 round of selections, data were downloaded from bamatracker.com as well as the New York Times website.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵^ Michael Mugavero (mmugavero{at}uabmc.edu) is the lead author for the COVID COMET RADXUP Team. Membership of the COVID COMET RADXUP Team is provided in the Acknowledgements.

  • Funding NIH RADx-Up initiative, UAB Center for AIDS Research, COVID COMET AL, Project #P30AI027767-32S1 (PI Michael Saag)

  • The funder provided support in the form of salaries for authors [LTM, DML, YY, SH, EBL, TC, MJM, and SEJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section

Data Availability

Data were downloaded periodically (approximately quarterly) from publicly available websites that collated and created visual representations of data reported by the Alabama Department of Public Health (ADPH). For the October 2020 county testing selections, data were downloaded from bamatracker.com, a website that collated and displayed data from ADPH through May 2021. In the March 2021 round of selections, data were downloaded from bamatracker.com as well as the New York Times website.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted February 01, 2023.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Using publicly available data to identify priority communities for a SARS-CoV-2 testing intervention in a southern U.S. state
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Using publicly available data to identify priority communities for a SARS-CoV-2 testing intervention in a southern U.S. state
Lynn T Matthews, Dustin M Long, Madeline C Pratt, Ya Yuan, Sonya L Heath, Emily B Levitan, Sydney Grooms, Thomas Creger, Aadia Rana, Michael J Mugavero, Suzanne E Judd
medRxiv 2023.01.31.23285248; doi: https://doi.org/10.1101/2023.01.31.23285248
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Using publicly available data to identify priority communities for a SARS-CoV-2 testing intervention in a southern U.S. state
Lynn T Matthews, Dustin M Long, Madeline C Pratt, Ya Yuan, Sonya L Heath, Emily B Levitan, Sydney Grooms, Thomas Creger, Aadia Rana, Michael J Mugavero, Suzanne E Judd
medRxiv 2023.01.31.23285248; doi: https://doi.org/10.1101/2023.01.31.23285248

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (427)
  • Allergy and Immunology (753)
  • Anesthesia (220)
  • Cardiovascular Medicine (3284)
  • Dentistry and Oral Medicine (362)
  • Dermatology (276)
  • Emergency Medicine (478)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1168)
  • Epidemiology (13346)
  • Forensic Medicine (19)
  • Gastroenterology (898)
  • Genetic and Genomic Medicine (5138)
  • Geriatric Medicine (480)
  • Health Economics (781)
  • Health Informatics (3260)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1189)
  • Hematology (428)
  • HIV/AIDS (1015)
  • Infectious Diseases (except HIV/AIDS) (14617)
  • Intensive Care and Critical Care Medicine (912)
  • Medical Education (476)
  • Medical Ethics (126)
  • Nephrology (522)
  • Neurology (4909)
  • Nursing (262)
  • Nutrition (725)
  • Obstetrics and Gynecology (880)
  • Occupational and Environmental Health (795)
  • Oncology (2517)
  • Ophthalmology (722)
  • Orthopedics (280)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (542)
  • Pediatrics (1299)
  • Pharmacology and Therapeutics (549)
  • Primary Care Research (555)
  • Psychiatry and Clinical Psychology (4198)
  • Public and Global Health (7489)
  • Radiology and Imaging (1703)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (979)
  • Rheumatology (479)
  • Sexual and Reproductive Health (496)
  • Sports Medicine (424)
  • Surgery (547)
  • Toxicology (72)
  • Transplantation (235)
  • Urology (203)